Phase 1-2a dose-ranging study of TLK286 [canfosfamide] in combination with cisplatin as first-line therapy in locally advanced or metastatic non-small cell lung cancer
Phase of Trial: Phase I/II
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Canfosfamide; Cisplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Sep 2005 New trial record.